Ophthalmology Science, 2025 Plasma Proteomic Markers of IL-1β Pathway Associated with Incident Age-related Macular Degeneration in Persons with AIDS Hunt P., Olshen A., Murad N. et al. Olink Explore 3072/384Infectious DiseasesOphthalmologyPatient StratificationPlasma | | | | |
Multiple Sclerosis and Related Disorders, 2025 Exploring the mediating role of cerebrospinal fluid metabolites in the pathway from circulating inflammatory proteins to multiple sclerosis: A Mendelian randomization study Mao X., Lu X., Liu Y. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
CHEST, 2025 Characterizing Sarcoidosis Patients with Obstructive Respiratory Physiology VanDerhoef D., Marka N., Langworthy B. et al. Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Aging Cell, 2025 Identifying PDAP1 as a Biological Target on Human Longevity: Integration of Mendelian Randomization, Cohort, and Cell Experiments Validation Study Hou T., Sha Z., Wang Q. et al. Olink Target 96Olink Explore 3072/384AgingPathophysiologyPlasma | | | | |
Nature Communications, 2025 Large-scale multi-omics analyses in Hispanic/Latino populations identify genes for cardiometabolic traits Petty L., Chen H., Frankel E. et al. Olink Explore 3072/384Metabolic DiseasesCross-platform Validation | | | | |
American Journal of Respiratory and Critical Care Medicine, 2025 Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung Disease Alqalyoobi S., Smith J., Maddali M. et al. Olink Explore 3072/384Respiratory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Clinical Cancer Research, 2025 Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma Jang H., Patel M., Wang D. et al. Olink Explore HTOncologyImmunotherapyPathophysiologyPlasma | | | | |
Nutrition & Metabolism, 2025 Unveiling the interplay among skin microbiota, cytokines, and T2DM: an insightful Mendelian randomization study Zhang Z., Jiang C., Xing Y. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Nature, 2025 Translational genomics of osteoarthritis in 1,962,069 individuals Hatzikotoulas K., Southam L., Stefansdottir L. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Nature Cancer, 2025 Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis Cousin S., Guégan J., Palmieri L. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Brain and Behavior, 2025 Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study Wang H., Cheng Z., Xu Z. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Cell, 2025 Human proteome distribution atlas for tissue-specific plasma proteome dynamics Malmström E., Malmström L., Hauri S. et al. Olink Explore 3072/384Wider Proteomics StudiesData SciencePlasma | | | | |
GeroScience, 2025 Associations between plasma proteomic signatures and secondary sleep in older adults Madhawa K., Svensson T., Nt H. et al. Olink Target 96NeurologyAgingPathophysiologyPlasma | | | | |
Scientific Reports, 2025 Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis Miclea A., Zurawski J., Healy B. et al. Olink Target 96NeurologyPatient StratificationSerum | | | | |
Thrombosis Journal, 2025 Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations Daghlas I., Wang M., Gill D. Olink Explore 3072/384CVDHematologyPathophysiologyPlasma | | | | |
npj Precision Oncology, 2025 Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment Cui S., Zheng H., Xu Y. et al. Olink Target 96OncologyImmunotherapyPatient StratificationPlasma | | | | |
Arthritis & Rheumatology, 2025 Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development Rachid Zaim S., Savage A., Gillespie M. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
Cell Genomics, 2025 Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity Donoghue L., Benner C., Chang D. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Cell Reports Medicine, 2025 Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients Hu M., Oliveira A., Fang Z. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Mediators of Inflammation, 2025 Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis Wu Z., Yang J., Zhu Y. et al. Olink Target 96AgingPathophysiologyPlasma | | | | |